Financial Highlights: Period Jan – Sep 2011
Sales grew by 13.2%
PBT fell by 9.8%
Sales grew by 13.2% to Rs. 4310 million. The profit before taxes fell by 9.8% to Rs. 767 million. Earnings after taxes fell by 12.9% to Rs. 510 million. An amount of Rs. 91.9 million was added to the fixed assets during Jan-Sep 2011. The Company has investments in Bank Deposits and Liquid funds of Rs. 1472 million.
Pharmaceuticals
The Pharmaceuticals business comprises of formulations used in areas of cardiovascular, metabolic diseases and vitamins. Sales in the Pharmaceuticals business sector grew by 15% to Rs. 3086. This sector accounts for 72% of the Company’s total sales.
Chemicals
The Chemicals business comprises of Bulk Pharma Compounds and Specialty Pigments. Sales in the Chemical business grew by 9% to Rs. 1224 million. This sector accounts for 28% of the Company’s total sales.
